Načítá se...
Emerging therapeutic targets for neurofibromatosis type 1 (NF1)
INTRODUCTION: Neurofibromatosis type 1 (NF1) is an autosomal dominantly inherited tumor predisposition syndrome with an incidence of one in 3000–4000 individuals with no currently effective therapies. The NF1 gene on chromosome 17 encodes neurofibromin, which functions as a negative regulator of RAS...
Uloženo v:
| Vydáno v: | Expert Opin Ther Targets |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7017752/ https://ncbi.nlm.nih.gov/pubmed/29667529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2018.1465931 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|